ArticleCirculation. Population health and outcomes2026
National Survival Estimates After Surgical Repair of Congenital Heart Disease.
Article in Circulation. Population health and outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSurvival estimates after congenital heart surgery (CHS) in the United States are essential for planning healthcare services for this growing, resource-intensive patient population. However, the absolute number of individuals living after interventions for congenital heart disease is unknown because nationally representative survival estimates are unavailable. Understanding postoperative survival from a representative national sample is a critical first step toward estimating the size and future healthcare needs of this population. This study aimed to develop nationally representative long-term survival estimates after CHS in the United States, focusing on benchmark procedures defined by the Society of Thoracic Surgeons.
methodsWe used 3 US data sets of children aged 0 to 20 years at the time of their benchmark CHS from 1998 to 2002 and surviving to hospital discharge. The Pediatric Cardiac Care Consortium (PCCC), a multi-institutional clinical registry, was matched to the National Death Index to determine mortality through December 2019. The Kids' Inpatient Database 2000, a nationally representative administrative claims data set, was used to derive age- and sex-specific weights. Kaplan-Meier curves were estimated from the PCCC-National Death Index cohort for benchmark operations, and Kids' Inpatient Database 2000 weights were applied. Unweighted PCCC survival estimates were also compared with those of Boston Children's Hospital, a large tertiary care center.
resultsNationally representative survival curves were generated for 7 benchmark CHS from 7973 cases; 3802 (48%) were female, and 4505 (57%) were infants at the time of CHS. These weighted national survival curves closely mirrored the unweighted curves derived from PCCC-National Death Index. Unweighted survival estimates from PCCC also closely approximated those from BCH, with only modest differences observed for selected lesions.
conclusionsThe weighted PCCC-National Death Index methodology provides the first nationally representative estimates of long-term survival after benchmark congenital heart disease in the United States. These estimates provide an important resource for healthcare planning and research for the growing population of individuals with congenital heart disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.